Member access

4-Traders Homepage  >  Shares  >  Toronto Stock Exchange  >  Transition Therapeutics Inc    TTH   CA8937162094

 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
02/26/2015 02/27/2015 03/02/2015 03/03/2015 03/05/2015 Date
8.55 8.6 8.7 8.6 8.45 Last
543 1411 1930 3800 1022 Volume
-5.00% +0.58% +1.16% -1.15% -1.74% Change
Company
Transition Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapeutics for disease indications with large markets.It operates through research and development of therapeutic agents segment.The company's products include ELND005 for the treatment of alzheimer's... 
Sector
Pharmaceuticals
Calendar
05/12Earnings Release
More about the company
Chart TRANSITION THERAPEUTICS IN
Duration : Period :
Transition Therapeutics In Technical Analysis Chart | TTH | CA8937162094 | 4-Traders
Full-screen chart
Financials ( CAD)
Sales 2015 0,83 M
EBIT 2015 -51,2 M
Net income 2015 -33,1 M
Debt 2015 -
Yield 2015 -
Sales 2016 1,67 M
EBIT 2016 -25,5 M
Net income 2016 -14,2 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 358x
Capi. / Sales 2016 179x
Capitalization 298 M
More Financials
Latest news on TRANSITION THERAPEUTICS IN
03/02 TRANSITION THERAPEUTICS : Announces Enrolment Completion of ELND005 Phase 2 Clin..
02/24 TRANSITION THERAPEUTICS INC : LifeSci Capital Initiates Coverage of Transition T..
02/19 TRANSITION THERAPEUTICS : to Present at the Cowen and Company 35th Annual Health..
02/18 TRANSITION THERAPEUTICS : Announces Closing of Public Offering of US$23 Million ..
02/12 TRANSITION THERAPEUTICS : Announces Pricing of Public Offering of US$20 Million ..
02/11 TRANSITION THERAPEUTICS : Announces Public Offering of Common Shares
02/09 TRANSITION THERAPEUTICS : Announces Second Quarter Fiscal 2015 Financial Results
02/05 TRANSITION THERAPEUTICS : to Hold Conference Call on Second Quarter Fiscal 2015 ..
More news
Sector news Biopharmaceuticals
03:18a NOVO NORDISK A/S : gennemfører succesfuld børsnotering af NNIT A/S
03:00a AstraZeneca keeps 2015 outlook after financial reporting change
03:00aDJAstraZeneca Reaffirms its 2015 Earnings Guidance
Plus d'actualités du secteur Biopharmaceuticals


Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF